mild cognitive impairment Clinical Trials and Research
Also known as: pre-dementia, amnestic cognitive impairment, non-amnestic cognitive impairment, early memory loss, cognitive impairment no dementia, mild neurocognitive disorder · ICD-10: G31.84
Mild cognitive impairment (MCI) involves a noticeable decline in memory or thinking skills, beyond normal aging, but not severe enough to impact daily life. Clinical trial research focuses on identifying early markers, understanding progression, and testing interventions to preserve cognitive function. Find a Trial helps patients search for active studies.
Search mild cognitive impairment trials →
Common questions about mild cognitive impairment clinical trials
Who can participate in clinical trials for mild cognitive impairment?
Eligibility criteria vary by study, but often include specific age ranges, confirmed MCI diagnosis, and certain cognitive test scores. Researchers also consider overall health and the absence of other neurological conditions. Data from ClinicalTrials.gov show diverse participant requirements.
What are the different phases of clinical trials for MCI?
Clinical trials typically progress through phases: Phase 1 assesses safety, Phase 2 evaluates effectiveness and dosage, and Phase 3 confirms efficacy and monitors side effects in larger groups. Phase 4 studies occur after a treatment is approved. This structured approach is consistent across trials listed on ClinicalTrials.gov.
Do clinical trials for mild cognitive impairment cost money to participate?
Generally, participants do not pay to join clinical trials. Study-related medical care, tests, and interventions are usually covered by the trial sponsor. However, costs like travel or lost wages are typically not covered. This information is often detailed on ClinicalTrials.gov.
What are current research directions for mild cognitive impairment?
Current research explores early detection methods, including biomarkers in blood and brain imaging, and interventions like new medications, lifestyle changes, and cognitive training. Studies aim to slow or prevent progression to dementia. This focus is evident in projects funded by NIH RePORTER and studies on ClinicalTrials.gov.
What types of interventions are being studied for MCI?
Interventions under investigation include pharmacological agents targeting underlying disease processes, non-pharmacological approaches like exercise and diet, and cognitive stimulation therapies. Researchers are also exploring digital health tools. These diverse strategies are cataloged on ClinicalTrials.gov.
What biomarkers are important in MCI research?
Important biomarkers include amyloid-beta and tau proteins, measured in cerebrospinal fluid or via PET scans, which are linked to Alzheimer's disease. Other markers involve brain imaging for atrophy and genetic factors. These are crucial for diagnosis and tracking disease progression in studies listed on ClinicalTrials.gov.
What might prevent someone from joining an MCI clinical trial?
Common exclusion criteria include other neurological conditions like stroke or Parkinson's, significant psychiatric disorders, or certain medical conditions that could interfere with study results. Specific medications or prior treatments might also be exclusionary. Details are always provided on ClinicalTrials.gov.
Are clinical trials for MCI focused on preventing progression to Alzheimer's disease?
Many MCI clinical trials specifically aim to identify ways to prevent or delay the progression of cognitive decline to Alzheimer's disease or other forms of dementia. This often involves targeting underlying pathological processes. This research focus is widely documented on ClinicalTrials.gov and NIH RePORTER.
How to find a mild cognitive impairment trial that fits you
- Describe your mild cognitive impairment situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all mild cognitive impairment trials →